New platform aims to predict cancer before it strikes
NCT ID NCT07469709
First seen Mar 16, 2026 · Last updated May 20, 2026 · Updated 13 times
Summary
This study is building a platform to better predict who is at risk for developing or having a recurrence of certain cancers, including breast, colon, ovarian, melanoma, and lung cancer. Researchers will analyze participants' blood and genetic information to find markers that could lead to earlier diagnosis. The goal is to catch cancer or its return before symptoms or scans show it, allowing for earlier treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo
RECRUITINGCandiolo, Turin, 10060, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.